A comprehensive view of Cancer. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

European Commission approves Merck’s KEYTRUDA pembrolizumab plus chemotherapy as neoadjuvant treatment, then continued as monotherapy as adjuvant treatment, for resectable non-small cell lung cancer at high risk of recurrence in adults

Eli Lilly Japan and Nippon Shinyaku sign alliance for pirtobrutinib in Japan, aiming to supply the drug for mantle cell lymphoma and chronic lymphocytic leukemia treatment; partnership focused on promoting proper use of the drug

Charles River partners with Singapore's Yong Loo Lin School of Medicine to develop and manufacture plasmid DNA for engineered stem cell cancer therapy; partnership to use Charles River's CDMO expertise in HQ and GMP-compliant plasmid DNA

Patent Issued for Antibody-drug-conjugate and its use for the treatment of cancer (USPTO 11918656)

MorphoSys receives US antitrust clearance for its proposed acquisition by Novartis, following clearance in Germany and Austria; the total equity value of the acquisition stands at €2.7B

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count